In Law360, IP Litigators Discuss Federal Circuit Ruling on Patent Venue Statute and Hatch-Waxman Act
Patent litigation over generic drugs, which has long been concentrated in Delaware and New Jersey, may spread out to more states across the country as a result of a recent Federal Circuit ruling, potentially making disputes more complicated,
In a Law360 article, IP litigation partner Matt Rizzolo (Washington, D.C.) provide insights on the patent venue statute and the Hatch-Waxman Act.
Matt expects the decision to be appealed further, and that there is a possibility that Congress could get involved to pass a new law.